Tap Consulting, LLC Curis Inc Transaction History

Tap Consulting, LLC

  • $487 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 26, 2022
SELL
$2.31 - $5.13 $57 - $128
-25 Closed
0 $0
Q4 2021

Jan 27, 2022
BUY
$4.45 - $8.09 $111 - $202
25 New
25 $0

About CURIS INC

CRIS Quotes by TradingView
  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $393M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Tap Consulting, LLC Portfolio

Follow Tap Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tap Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tap Consulting, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email